Help! Please Register

  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: The Fungi > Descriptions >


Syncephalastrum spp.
described by Schröter in 1886

Say Me

Taxonomic classification

Kingdom: Fungi
Phylum: Zygomycota
Class: Zygomycetes
Order: Mucorales
Family: Syncephalastraceae
Genus: Syncephalastrum

Description and Natural Habitats

Syncephalastrum is a filamentous fungus that is commonly isolated from soil and animal feces particularly in tropical and subtropical areas. It is a heterothallic fungus and requires a mating strain to produce zygospores. Syncephalastrum is commonly considered as a contaminant. It is very rarely associated with human disease.

Species

The genus Syncephalastrum contains a single species; Syncephalastrum racemosum. See the summary of synonyms and obselete names for the Syncephalastrum spp.

Pathogenicity and Clinical Significance

Syncephalastrum is a very rare causative agent of human zygomycosis [1918]. It has so far been isolated in cases of cutaneous infection [531] and otomycosis.

Macroscopic Features

Colonies of Syncephalastrum grow very rapidly and fill the petri dish or culture tube. Maximum growth temperature is 40°C. The texture is wooly to cotton candy-like. From the front, the color is white initially and turns to dark gray to black in time. Reverse is pale or yellowish-brown [531, 1295, 2144, 2202].

Microscopic Features

Broad (4-8 µm in diameter), nonseptate or sparsely septate hyphae, sporangiophores, merosporangia (finger-shaped, tubular sporangia), (mero)sporangiospores (=merospores), and rhizoids are visualized. Septation of the hyphae is mostly observed as the culture gets old. Sporangiophores are frequently branched and rather short. They end up in a vesicle (80 µm in diameter). Around this vesicle are the merosporangia (4-6 x 9-60 µm), which are filled with linear series (chains) of sporangiospores. Each merosporangium contains a single row of 3-18 merosporangiospores. Merosporangiospores (3-7 µm, may rarely reach 10 µm in diameter) are one-celled and spherical to cylindrical in shape [531, 1295, 2144, 2202].

Zygospores, when produced, are black, spherical, and 50-90 µm in diameter. They have conical projections [531].

Histopathologic Features

Aseptate or sparsely septate hyphae may be observed. See also our histopathology page.

Compare to

Aspergillus
Cunninghamella

Syncephalastrum differs from Aspergillus by the presence of merosporangia and absence of phialides.

Laboratory Precautions

No special precautions other than general laboratory precautions are required.

Susceptibility

Very limited data are available. Amphotericin B, ketoconazole, and itraconazole MICs are low while those of voriconazole are relatively high for isolates of Syncephalastrum racemosum [2432]. Terbinafine and naftifine have no meaningful in vitro activity against Syncephalastrum [2308].

For MICs of various antifungal drugs for Syncephalastrum racemosum, see our susceptibility database.

Search

PubMed

Nucleotides

GenBank



Syncephalastrum
Syncephalastrum racemosum



References

531. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed, vol. 1. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.

1295. Larone, D. H. 1995. Medically Important Fungi - A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.

1918. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin Microbiol Rev. 13:236-301.

2144. St-Germain, G., and R. Summerbell. 1996. Identifying Filamentous Fungi - A Clinical Laboratory Handbook, 1st ed. Star Publishing Company, Belmont, California.

2202. Sutton, D. A., A. W. Fothergill, and M. G. Rinaldi (ed.). 1998. Guide to Clinically Significant Fungi, 1st ed. Williams & Wilkins, Baltimore.

2308. Venugopal, P. V., and T. V. Venugopal. 1994. Antifungal activity of allylamine derivatives. Indian J Med Res. 99:71-3.

2432. Wildfeuer, A., H. P. Seidl, I. Paule, and A. Haberreiter. 1998. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses. 41:309-319.



  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif